Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of an antitumor agent in female patients (Japan)
jRCT2080222420Phase 3Completed
- Start
- Mar 2014
01
Overview
Phase 3 trial in cancer. Started Mar 2014; status: completed.
02
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080222420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222420.